西安天美生物科技宣布2021財年財報創(chuàng)下新高

收入增加（減少）

毛利潤增加（減少）

香料原料

61.7%

82.3%

膳食補充劑（固體飲料）

71.2%

81.8%

生物活性食品原料

(5.6%)

(14.2%)

In the United States:

In China:

Maggie Zhang | Impact IR

Sophie Zhang | Impact IR

Phone: (646) 893-8916

Email: sophie.zhang@irimpact.com

Email: maggie.zhang@irimpact.com 

For the Years Ended September 30,

2021

2020

2019

REVENUE

$

25,494,564

$

18,219,959

$

16,396,018

COST OF REVENUE

(18,382,637)

(13,017,646)

(11,113,922)

GROSS PROFIT

7,111,927

5,202,313

5,282,096

OPERATING EXPENSES

Selling expenses

(138,530)

(161,719)

(273,841)

General and administrative expenses

(1,323,726)

(1,367,070)

(1,310,215)

Research and development expenses

(249,050)

(205,359)

(522,867)

Total operating expenses

(1,711,306)

(1,734,148)

(2,106,923)

INCOME FROM OPERATIONS

5,400,621

3,468,165

3,175,173

OTHER INCOME (EXPENSES)

Interest income

3,207

714

2,271

Interest expense

(417,266)

(329,102)

(333,190)

Unrealized foreign transaction exchange gain (loss)

(45,124)

(248)

5,281

Gain on disposal of fixed assets

-

20,150

-

Government subsidies

449,972

362,187

140,295

Income from short-term investments

565

-

-

Other income

38,409

132,713

-

Total other income (expenses), net

29,763

186,414

(185,343)

INCOME BEFORE INCOME TAX PROVISION

5,430,384

3,654,579

2,989,830

INCOME TAX PROVISION

(820,931)

(556,262)

(427,194)

NET INCOME

4,609,453

3,098,317

2,562,636

Less: net income (loss) attributable to non-controlling interest

18,650

71,644

(11,167)

NET INCOME ATTRIBUTABLE TO BON NATURAL LIFE LIMITED

$

4,590,803

$

3,026,673

$

2,573,803

OTHER COMPREHENSIVE INCOME (LOSS)

Total foreign currency translation adjustment

612,806

450,234

(281,699)

TOTAL COMPREHENSIVE INCOME

5,222,259

3,548,551

2,280,937

Less: comprehensive income (loss) attributable to non-controlling interest

21,133

81,737

(10,969)

COMPREHENSIVE INCOME ATTRIBUTABLE TO BON NATURAL LIFE LIMITED

$

5,201,126

$

3,466,814

$

2,291,906

EARNINGS PER SHARE

Basic

$

0.69

$

0.58

$

0.50

Diluted

$

0.68

$

0.58

$

0.50

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING

Basic

6,615,833

5,210,649

5,166,667

Diluted

6,706,235

5,210,649

5,166,667

For the Years Ended September 30,

2021

2020

2019

Cash flows from operating activities

Net income

$

4,609,453

$

3,098,317

$

2,562,636

Adjustments to reconcile net income to cash provided by operating activities

Allowance for doubtful accounts

2,948

22,137

34,328

Depreciation and amortization

228,547

230,597

226,633

Inventory reserve (recovery)

(312,532)

29,539

-

Deferred income tax

29,109

(7,751)

(5,149)

Amortization of operating lease right-of-use assets

58,147

-

Amortization of stock options

44,910

-

-

Unrealized foreign currency exchange loss (gain)

45,124

248

(5,281)

Gain on disposal of property and equipment

-

(20,150)

-

Changes in operating assets and liabilities:

Accounts receivable

(89,543)

(284,546)

(2,912,222)

Inventories

(209,011)

1,636,321

6,681,972

Advance to suppliers, net

(399,262)

(3,021,739)

168,868

Prepaid expenses and other current assets

2,642

72,116

173,609

Accounts payable

(969,414)

(1,982,205)

(78,356)

Operating lease liabilities

(49,648)

-

-

Taxes payable

410,716

2,662,542

1,538,662

Deferred revenue

684,030

161,045

(1,223,824)

Accrued expenses and other current liabilities

(33,092)

46,605

(57,053)

Net cash provided by operating activities

4,053,124

2,643,076

7,104,823

Cash flows from investing activities

Purchase of short-term investments

(2,159,920)

-

-

Proceeds upon redemption of short-term investments

470,082

-

-

Purchase of property and equipment

(51,878)

(31,885)

(213,634)

Capital expenditures on construction-in-progress

(4,432,941)

(4,301,103)

(6,861,257)

Purchase of intangible assets

(269,088)

-

-

Refund (payment) of acquisition deposit

(1,000,000)

1,329,945

(1,355,067)

Net cash used in investing activities

(7,443,745)

(3,003,043)

(8,429,958)

Cash flows from financing activities

Net proceeds from issuance of Ordinary Shares in initial public offerings

11,271,480

-

-

Proceeds from short-term loans

1,257,225

2,033,570

4,008,293

Proceeds from long-term loans

1,245,871

319,342

-

Repayment of short-term loans

(2,563,433)

(2,872,778)

(4,514,482)

Repayment of long-term loans

(2,522,101)

-

-

Proceeds from (repayment of) borrowings from related parties

(2,262,378)

1,067,808

543,976

Proceeds from (repayment of) third party loans

(721,484)

238,133

(101,793)

Principal payment from (repayment of) finance lease

169,153

(392,030)

432,722

Capital contribution from non-controlling interest

-

-

435,964

Payment for deferred initial public offering costs

(521,651)

(281,553)

-

Net cash provided by financing activities

5,352,682

112,492

804,680

Effect of changes of foreign exchange rates on cash

(111,300)

6,810

(6,630)

Net increase (decrease) in cash

1,850,761

(240,665)

(527,085)

Cash, beginning of year

53,106

293,771

820,856

Cash, end of year

$

1,903,867

$

53,106

$

293,771

Supplemental disclosure of cash flow information

Cash paid for interest expense

$

417,266

$

276,671

$

333,190

Cash paid for income tax

$

2,411

$

-

$

115,179

Supplemental disclosure of non-cash investing and financing activities

Amortization of share-based compensation for initial public offering services

$

422,221

$

211,112

$

-

Right-of-use assets obtained in exchange for operating lease obligations

$

257,564

$

-

$

-

Reconciliation of Adjusted EBITDA to Net Income

 30-Sep

2021

2020

 Net income

$

4,609,453

$

3,098,317

 Interest expense

417,266

329,102

 Income taxes

820,931

556,262

 Depreciation and amortization

228,547

230,597

44,910

-

$

6,121,107

$

4,214,278